Networking in Barcelona
Nature News / July 23, 2008
German public-private partnership breaks ground
For the first time in its 60-year history, Germany’s Max Planck Society (MPS) is setting up a new institute using private money – €200 million (US$317 million) of it. On 15 July, the twin brothers who founded the generic drugs company Hexal signed an agreement with the MPS to establish an institute for cognitive neuroscience in Frankfurt. The institute is set to start work by the end of this year.
The Ernst Strüngmann Institute is named after the father of Hexal founders Andreas and Thomas Strüngmann. It will have the same scientific independence as the 80 other MPS institutes, but unlike them its finances will be overseen by a separate board, on which Andreas Strüngmann will sit.
“Public-private research is a well established concept in the United States, but not yet in Germany,” says Wolf Singer, director of the Max Planck Institute for Brain Research in Frankfurt and provisional head of the new institute. “I hope this model will become common practice.”